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Hyperglycaemia in pregnancy is an issue of increasing 
concern to health-care providers and administrators. 
The ﬁ rst and most obvious reason is its increasing 
prevalence, mostly due to the same reasons that are 
driving the epidemic of obesity and type 2 diabetes 
almost worldwide. The second reason is related to the 
ﬁ ndings of the HAPO study 1 of strong, continuous 
associations between maternal glucose concentrations 
and increased risk of adverse outcomes in their 
oﬀ spring. The study resulted in the development of a 
new deﬁ nition of criteria for diagnosis of gestational 
diabetes, initially proposed by the International 
Association of Diabetes and Pregnancy Study Groups,2 
and later endorsed by WHO, with much debate. The 
third reason is the emerging evidence that the metabolic 
changes that result in gestational diabetes and type 2 
diabetes might be passed onto future generations.3 
In The Lancet Diabetes & Endocrinology, Diane Farrar and 
colleagues4 present important data to supplement what 
is known about gestational diabetes. The researchers 
studied the association of hyperglycaemia with adverse 
outcomes in a similar way to the HAPO study, in a large 
cohort of south Asian and white British women living in 
the Bradford area in the UK. Women from south Asian 
countries with large populations such as Pakistan, India, 
Sri Lanka, and Bangladesh were poorly represented in the 
HAPO study, and are known to have high prevalence of 
type 2 diabetes and gestational diabetes. Therefore, the 
data presented by Farrar and colleagues are important 
for a large population of women. The  ﬁ ndings conﬁ rm 
those of the HAPO study, and also show a continuous 
and graded association between concentrations of 
fasting and 2 h post-load glucose (as measured in a 
maternal oral glucose tolerance test between gestational 
week 26 and 28) and the newborn’s risk of being large 
for gestational age (LGA), with high adiposity (measured 
as the sum of skinfolds >90th percentile), and for the 
women having a caesarean section. The results also show 
important diﬀ erences between south Asian and white 
British women. 
Farrar and colleagues report that the glucose 
concentrations that were associated with increased 
risk for certain adverse outcomes diﬀ ered between 
the south Asian and the British women.4 For example, 
the thresholds of fasting plasma glucose that deﬁ ned 
a woman’s risk of having an infant with birthweight 
greater than the 90th percentile were 5·6 mmol/L for 
white British versus 5·1 mmol/L for south Asian women. 
DNA methylation eﬀ ects of the Dutch Hunger Winter.4,8 
These ﬁ ndings, in addition to emerging data emphasising 
the eﬀ ect of ﬁ rst-trimester weight gain and changes 
in adiposity on maternal and oﬀ spring obesity-related 
outcomes,9,10 suggest that a focus on preconception and 
periconception should constitute the next frontier for 
prevention of diabetes over the life course. 
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The ﬁ ndings could point to diﬀ erences in the eﬀ ect that 
maternal glycaemia has in groups with diﬀ erent genetic 
or environmental exposures. However, the results might 
also be due to additional factors related to glucose, 
such as maternal bodyweight and fat mass, gestational 
weight gain, and lipid concentrations.  Researchers have 
yet to ascertain the most important factors aﬀ ecting 
oﬀ spring metabolic health in adulthood.
In Farrar and colleagues’ study, the incidence of LGA 
babies was only about a third in the south Asian group 
compared with the white British group, whereas babies 
with sum of skinfolds greater than the 90th percentile 
did not diﬀ er between groups.4 Similar ﬁ ndings have 
been published before5 and could point to important 
diﬀ erences between the two ethnic groups. Previous 
ﬁ ndings have shown that newborns of south Asian 
women generally have lower birthweight and a 
higher tendency to be small for gestational age than 
do newborns of white women. Not only large-for-
gestational-age babies but also small-for-gestational-
age babies have increased risk for obesity, insulin 
resistance, and type 2 diabetes in adulthood. Some 
of the most important early ﬁ ndings showing this 
phenomenon came from Barker’s studies of children 
born almost 100 years ago.6 The ﬁ ndings have since 
been conﬁ rmed in diﬀ erent populations, and including 
in Indian children in the prospective Pune Maternal 
Nutrition Study.7 Researchers noted that small and 
thin Indian babies were more adipose than larger 
English babies, and they had higher risk of future type 
2 diabetes that was associated with insulin resistance at 
birth. The U-shaped association between birthweight 
and adult risk of type 2 diabetes has been ascribed to 
maternal nutritional factors, and recent research has 
focused on possible links via epigenetic mechanisms 
whereby environmental exposures in utero might lead 
to changes in oﬀ spring DNA (methylation, histone 
modiﬁ cations, and microRNAs).8 
The ﬁ rst criteria to diagnose gestational diabetes 
were established to identify pregnant women who 
were at increased risk for development of type 2 
diabetes after pregnancy.9 Although there is a shift to 
changing the criteria to focus on infant outcomes,  the 
risk of the mother is still important, as women who 
have been diagnosed with gestational diabetes are 
among those with the highest risk of developing type 2 
diabetes later in life. In view of ﬁ ndings of intervention 
studies showing that programmes focusing on healthy 
nutrition and increased physical activity can reduce the 
risk for developing type 2 diabetes by about 50% in 
such high risk groups,10 health-care providers have to 
face the challenge to take care of both the women and 
the children during and after  birth.      
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